19.02.2013 14:50 Uhr, Quelle: Wallstreet online
Sobi and Savient Pharmaceuticals Announce Co-Promotion Agreement for Kineret® (anakinra) in the U.S.
CONTACT: Swedish Orphan Biovitrum (Sobi) ABAlan RaffenspergerChief Operating Officer+46 8 697 20 90 Savient Pharmaceuticals, Inc. John P. HamillSenior Vice President and Chief Financial Officerinformation@savient.com …
Weiterlesen bei Wallstreet online
JustMac.info